Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $140.65 in the prior trading day, Sarepta Therapeutics Inc (NASDAQ: SRPT) closed at $138.91, down -1.24%. In other words, the price has decreased by -$1.24 from its previous closing price. On the day, 0.55 million shares were traded. SRPT stock price reached its highest trading level at $140.97 during the session, while it also had its lowest trading level at $138.14.
Ratios:
Our goal is to gain a better understanding of SRPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.90. In the meantime, Its Debt-to-Equity ratio is 1.27 whereas as Long-Term Debt/Eq ratio is at 1.19.
On June 26, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $172 to $176.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $157.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $157 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 16 ’24 when Chambers Michael Andrew bought 37,038 shares for $133.80 per share. The transaction valued at 4,955,728 led to the insider holds 284,034 shares of the business.
Brown Ryan Edward sold 38,957 shares of SRPT for $6,296,029 on Jun 25 ’24. The EVP, General Counsel now owns 17,129 shares after completing the transaction at $161.61 per share. On Jun 24 ’24, another insider, Arif Bilal, who serves as the Chief Tech Ops Officer of the company, sold 7,859 shares for $163.08 each. As a result, the insider received 1,281,621 and left with 21,261 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRPT now has a Market Capitalization of 13413274624 and an Enterprise Value of 13173907456. As of this moment, Sarepta’s Price-to-Earnings (P/E) ratio for their current fiscal year is 343.41, and their Forward P/E ratio for the next fiscal year is 12.15. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.80 while its Price-to-Book (P/B) ratio in mrq is 12.29. Its current Enterprise Value per Revenue stands at 8.753 whereas that against EBITDA is 169.439.
Stock Price History:
Over the past 52 weeks, SRPT has reached a high of $173.25, while it has fallen to a 52-week low of $55.25. The 50-Day Moving Average of the stock is -3.60%, while the 200-Day Moving Average is calculated to be 13.32%.
Shares Statistics:
The stock has traded on average 1.91M shares per day over the past 3-months and 767620 shares per day over the last 10 days, according to various share statistics. A total of 93.73M shares are outstanding, with a floating share count of 89.46M. Insiders hold about 6.19% of the company’s shares, while institutions hold 92.43% stake in the company. Shares short for SRPT as of 1723680000 were 6730587 with a Short Ratio of 3.53, compared to 1721001600 on 7332218. Therefore, it implies a Short% of Shares Outstanding of 6730587 and a Short% of Float of 7.380000000000001.
